Zomedica Corp. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Zomedica Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2022.
  • Zomedica Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
  • Zomedica Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8K.
  • Zomedica Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $219M, a 186% increase from 2020.
  • Zomedica Corp. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $76.7M, a 415% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $0 -$217M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $292M $217M +$215M +9997% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $76.7M $12.6M +$12.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $64M $28.6M +$28.6M Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $35.4M $33.3M +$21.4M +178% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $14M $2.15M -$855K -28.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $14.9M -$81K -$4.84M -102% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $19.7M -$1.41K* -$87.8K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $19.8M $12M +$7.96M +198% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $11.9M $3.01M +$1.6M +114% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $10.3M $4.76M +$3.88M +443% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $6.38M $86.4K -$3.28M -97.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $9.65M $4.01M +$1.01M +33.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $8.64M $1.41M +$1.16M +460% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $7.49M $876K Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 $3.36M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $252K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.